Reference
1. Desai M, ter Kuile FO, Nosten F, Mcgready R, Asamoa K. Epidemiology and burden of malaria in pregnancy. Lancet Infectious Diseases. 2007;7(2):93-104.
2. Duffy PE, Fried M. Malaria in the Pregnant Woman; 2005; 295:169–200..
3. Walker PGT, ter Kuile FO, Garske T, Menendez C, Ghani AC. Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study. Lancet Glob Health. 2014;2(8):e460-e7.
4. The PREGACT Study Group. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. N Engl J Med. 2016;374(10):913-27.
5. White NJ, Olliaro PL. Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria. Parasitol Today. 1996;12(10):399-401.
6. World Health Organization. Guidelines for the treatment of malaria. World Health Organization. 2006;6(2):632-46.
7. Shulman CE, Dorman EK, Cutts F, Kawuondo K, Marsh K. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet. 1999;353(9153):632-6.
8. Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. Jama. 2013 Feb 13;309(6):594-604.
9. Gutman J, Kalilani L, Taylor S, Zhou Z, Wiegand RE, Thwai KL, et al. The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women. Journal of Infectious Diseases. 2015;211(12):1997-2005.
10. Iriemenam NC, Shah M, Gatei W, Eijk AMV, Ayisi J, Kariuki S, et al. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malaria Journal. 2012;11(1):134.
11. World Health Organization. Guidelines for the treatment of malaria. Third edition April 2015. 2015 2015:316.
12. Kakuru A, Staedke S, Chandramohan D, Kajubi R, Andra T, Adrama H, et al. Impact of intermittent preventive treatment of malaria in pregnancy with monthly dihydroartemisinin-piperaquine on the incidence of malaria during infancy. American Journal of Tropical Medicine and Hygiene. 2018;99(4):663.
13. Desai M, Gutman J, L’Lanziva A, Otieno K, Juma E, Kariuki S, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: An open-label, three-group, randomised controlled superiority trial. The Lancet. 2015;386(10012):2507-19.
14. Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, et al. Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy. New England Journal of Medicine. 2016;374(10):928-39.
15. Myint HY, Ashley EA, Day NPJ, Nosten F, White NJ. Efficacy and safety of dihydroartemisinin-piperaquine. Trans R Soc Trop Med Hyg. 2007;101(9):858-66.
16. Li L, Tian J, Tian H, Moher D, Liang F, Jiang T, et al. Network meta-analyses could be improved by searching more sources and by involving a librarian. Journal of Clinical Epidemiology. 2014;67(9):1001-7.
17. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011 Oct 18;343:d5928.
18. Ge L, Tian JH, Li YN, Pan JX, Li G, Wei D, et al. Association between prospective registration and overall reporting and methodological quality of systematic reviews: a meta-epidemiological study. Journal of Clinical Epidemiology. 2018;93:S0895435617300458.
19. Norris SL, Meerpohl JJ, Akl EA, Schünemann HJ, Gartlehner G, Chen Y, et al. The skills and experience of GRADE methodologists can be assessed with a simple tool. Journal of Clinical Epidemiology. 2016;79:S0895435616301937.
20. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327(7414):557-60.
21. Dawid P, Roland Brian B, Lun L, Barbara P, Michaela E. Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties. Journal of Clinical Epidemiology. 2015;68(5):574-83.
22. Madanitsa M, Kalilani L, Mwapasa V, van Eijk AM, Khairallah C, Ali D, et al. Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial. PLoS Medicine. 2016;13(9).
23. Jagannathan P, Kakuru A, Okiring J, Muhindo MK, Natureeba P, Nakalembe M, et al. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial. PLoS Medicine. 2018;15(7).
24. Kajubi R, Ochieng T, Kakuru A, Jagannathan P, Nakalembe M, Ruel T, et al. Monthly sulfadoxine–pyrimethamine versus dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial. The Lancet. 2019;393(10179):1428-39.
25. Lawn JE, Blencowe H, Oza S, You D, Lee AC, Waiswa P, et al. Every Newborn: progress, priorities, and potential beyond survival. Lancet. 2014 Jul 12;384(9938):189-205.
26. Sowunmi A, Akano K, Ayede AI, Adewoye EO, Ntadom G, Fatunmbi B, et al. Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria. BMC infectious diseases. 2017 Jan 31;17(1):110.
27. Reyburn H. New WHO guidelines for the treatment of malaria. BMJ. 2010;340(may28 1):c2637-c.
28. Tongo OO, Orimadegun AE, Akinyinka OO. Utilisation of malaria preventive measures during pregnancy and birth outcomes in Ibadan, Nigeria. Bmc Pregnancy & Childbirth. 2011;11(1):60-.
29. Chico RM, Chaponda EB, Ariti C, Chandramohan D. Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections. Clinical Infectious Diseases. 2017;64(8):1043-51.
30. Li XX, Zheng Y, Chen YL, Yang KH, Zhang ZJ. The reporting characteristics and methodological quality of Cochrane reviews about health policy research. Health Policy. 2015;119(4):503-10.
31. Guyatt HL, Snow RW. Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clinical microbiology reviews. 2004 Oct;17(4):760-9, table of contents.
32. Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, et al. Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America. 2015;62(3):civ881.
33. Schwarz N, Adegnika A, Lp, Gabor J, Agnandji S, Newman R, Lell B, et al. Placental malaria increases malaria risk in the first 30 months of life. Clinical Infectious Diseases. 2008;47(8):1017-25.
34. Gutman J, Kovacs S, Dorsey G, Stergachis A, Kuile FOT. Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis. Lancet Infectious Diseases. 2017;17(2):184-93.
35. Tian J, Zhang J, Ge L, Yang K, Song F. The methodological and reporting quality of systematic reviews from China and the USA are similar. J Clin Epidemiol. 2017 May;85:50-8.
36. Shulman CE, Dorman EK, Talisuna AO, Lowe BS, Nevill C, Snow RW, et al. A community randomized controlled trial of insecticide-treated bednets for the prevention of malaria and anaemia among primigravid women on the Kenyan coast. Tropical medicine & international health : TM & IH. 1998 Mar;3(3):197-204.
37. Feng G, A. SJ, Ebbie C, E. MM, J. RS, Georges S. Decreasing Burden of Malaria in Pregnancy in Malawian Women and Its Relationship to Use of Intermittent Preventive Therapy or Bed Nets. Plos One. 2010;5(8):e12012.
38. Gamble C, Ekwaru JP, ter Kuile FO. Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database of Systematic Reviews. 2006;2(2):CD003755.
39. Ter Kuile FO, Parise ME, Verhoeff FH, Udhayakumar V, Newman RD, van Eijk AM, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. American Journal of Tropical Medicine & Hygiene. 2004;71(2 Suppl):41.
40. Olaleye A, Okusanya BO, Oduwole O, Esu E, Meremikwu M. A systematic review and meta-analysis of dihydroartemisinin-piperaquine versus sulphadoxine-pyrimethamine for malaria prevention in pregnancy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2019 Jul;146(1):43-55.
41. Yao L, Sun R, Chen YL, Wang Q, Wei D, Wang X, et al. The quality of evidence in Chinese meta-analyses needs to be improved. Journal of Clinical Epidemiology. 2016;74:73-9.